Reply to Letter to the Editor: "COVID-19: is the ACE2 just a foe?"

Abassi, Zaid A; Skorecki, Karl; Heyman, Samuel N; Kinaneh, Safa; Armaly, Zaher

Abassi, Zaid A; Skorecki, Karl; Heyman, Samuel N; Kinaneh, Safa; Armaly, Zaher.

Afiliación

Abassi ZA; Department of Physiology and Biophysics, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Skorecki K; Laboratory Medicine, Rambam Medical Center, Haifa, Israel.
Heyman SN; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Kinaneh S; Department of Medicine, Hadassah Hebrew University Hospital, Mt. Scopus, Jerusalem, Israel.
Armaly Z; Department of Physiology and Biophysics, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Am J Physiol Lung Cell Mol Physiol ; 318(5): L1031, 2020 05 01.

Article en En | MEDLINE | ID: mdl-32364443

Asunto(s)

Betacoronavirus; Neumonía Viral; Enzima Convertidora de Angiotensina 2; COVID-19; Infecciones por Coronavirus; Humanos; Pandemias; Peptidil-Dipeptidasa A; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía Viral / Betacoronavirus Límite: Humans Idioma: En Revista: Am J Physiol Lung Cell Mol Physiol Asunto de la revista: BIOLOGIA MOLECULAR / FISIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Israel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google